Method for treating a blood component containing sample

US9816994B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9816994-B2
Application numberUS-201615161170-A
CountryUS
Kind codeB2
Filing dateMay 20, 2016
Priority dateJun 20, 2012
Publication dateNov 14, 2017
Grant dateNov 14, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a treatment method for damaging an erythrocyte and a leukocyte while suppressing damage to cells other than blood cells present in blood. In an embodiment, the disclosure relates to a method for treating a sample containing blood components, the method including mixing a sample containing blood components with a surfactant A, where the surfactant A is a nonionic surfactant represented by General formula R 1 —O—(EO)n-R 2 (I).

First claim

Opening claim text (preview).

What is claimed is: 1. A method for separating or detecting a tumor cell and/or a cancer cell in a sample containing blood components, the method comprising treating the sample by mixing the sample with a liquid containing a surfactant A, wherein no fixation agent is used, and the surfactant A is a nonionic surfactant represented by formula (I) R 1 —O-(EO) n -R 2   (I) wherein: R 1 is a hydrocarbon group having a branched chain and having a carbon number in the range of 12 to 40, EO is an oxyethylene group, n is an average addition mole number of EO in the range of 23 to 50, and R 2 is a hydrogen atom or a hydrocarbon group having a carbon number in the range of 1 to 3, wherein the method eliminates erythrocytes and leukocytes present in the sample while suppressing damage to the tumor cell and/or the cancer cell. 2. The method according to claim 1 , wherein the surfactant A is a polyoxyethylene alkylene ether with an EO in a range of 23 to 35. 3. The method according to claim 1 , wherein the liquid containing the surfactant A satisfies a blood cell elimination effect as described in (1) below: (1) preparing a control sample by diluting a predetermined amount of blood with distilled water so that an absorbance value measured by absorption photometry using a micro-plate reader and light of a wavelength of not less than 600 nm is not less than 1 and is less than 2; and preparing a test sample from a liquid containing 2.5 to 5 w/v % of the surfactant A, so that the time for the absorbance value of the test sample measured by absorption photometry by light having a wavelength of not less than 600 nm to be decreased to half of the absorbance value of the control sample is not more than one hour.

Assignees

Inventors

Classifications

  • G01N33/575Primary

    for cancer · CPC title

  • Preparing specimens for investigation {including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q}(mounting specimens on microscopic slides G02B21/34; means for supporting the objects or the materials to be analysed in electron microscopes H01J37/20 {; laboratory gas handling apparatus B01L5/00}) · CPC title

  • Partitioning blood components · CPC title

  • G01N33/574Primary

    Physics · mapped topic

  • from cyclic ethers and other compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9816994B2 cover?
Provided is a treatment method for damaging an erythrocyte and a leukocyte while suppressing damage to cells other than blood cells present in blood. In an embodiment, the disclosure relates to a method for treating a sample containing blood components, the method including mixing a sample containing blood components with a surfactant A, where the surfactant A is a nonionic surfactant represent…
Who is the assignee on this patent?
Arkray Inc
What technology area does this patent fall under?
Primary CPC classification G01N33/575. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).